Announced Mon, 3 Aug · 15:27 IST
Trident Lifeline Q1 FY27 earnings: revenue up 43 percent, PAT up 82 percent YoY
Mgmt Guided Margin ImprovementPromoter Disclosed Acquisition PlansAnalyst Day Multiyear TargetsInvestor Communications View source PDFExplain this filing
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.1%1-day move
₹263.10
prior close
₹263.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.1-3.4-3.4-1.8-0.8-0.4+3.6+3.7——
Up moveDown movePending
AI summary
Trident Lifeline reported Q1 FY27 consolidated revenue of 33.7 cr (+43% YoY), EBITDA 8.5 cr (+65%), PAT 5.1 cr (+82%). Margins expanded with EBITDA margin +334 bps to 25.3%. FY26 revenue 129 cr (+48%), PAT 19.3 cr (+84%). Company crossed 100 cr revenue milestone. Management aspires to triple consolidated business over 3 years. Subsidiaries scaling in injectables, medical devices, nutraceuticals and cosmetics. Presence in 46 countries with 2,534 registrations filed.
Likely market impact
Strong growth across revenue, margins and profits with multi-year scaling plan. Positive for shareholders; execution risk remains on 3x target.